---
title: Cox Enterprises Social Impact Accelerator Class 2021 - Acclinate
description: Ten companies were selected to address systematic racism and social justice
image: https://blog.acclinate.com/hubfs/64ee7ebf711c42cfdd7be9a7_bZtPp92g.jpeg
---

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
    - [eDICT](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros)
    - [Partners](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [About Us](https://www.acclinate.com/about)
    - [Careers](https://www.acclinate.com/careers)
    - [News](https://news.acclinate.com)
- Resources 
    - [Resource Library](https://www.acclinate.com/resources)
    - [Blog](https://blog.acclinate.com)
    - [Press Kit](https://www.acclinate.com/press-kit)
    - [Events](https://www.acclinate.com/events)
    - [Glossary](https://www.acclinate.com/glossary)
    - [FAQ](https://www.acclinate.com/faq)
- [Talk to Our Team](https://info.acclinate.com/get-in-touch)

[![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302)

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [**NOWINCLUDED**Acclinate’s B2C community platform
      
      ](https://www.acclinate.com/products/nowincluded-the-community)
    - [**e-DICT**Acclinate’s patented AI-powered technology
      
      ](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials.
      
      ](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines.
      
      ](https://www.acclinate.com/solutions/for-cros)
    - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve.
      
      ](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation.
      
      ](https://www.acclinate.com/about)
    - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation.
      
      ](https://www.acclinate.com/careers)
- Resources 
    - [**Resources Hub**
      
      ](https://www.acclinate.com/resources)
    - [**Glossary**
      
      ](https://www.acclinate.com/glossary)
    - [**Press Kit**
      
      ](https://www.acclinate.com/press-kit)
    - [**Events**
      
      ](https://www.acclinate.com/events)
    - [**Blog**
      
      ](https://blog.acclinate.com/)
    - [**News**
      
      ](https://news.acclinate.com/)
    - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png)
      
      **FAQs**
      
      ](https://www.acclinate.com/faq)
- [ Contact Us ](https://www.acclinate.com/contact-us)

Stay up to date

 Get news directly in your inbox

Topic

 All

- [Affective Trust ](https://blog.acclinate.com/tag/affective-trust)
- [Announcement ](https://blog.acclinate.com/tag/announcement)
- [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software)
- [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies)
- [Community ](https://blog.acclinate.com/tag/community)
- [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials)
- [e-DICT™ ](https://blog.acclinate.com/tag/e-dict)
- [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan)
- [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials)
- [Health Equity ](https://blog.acclinate.com/tag/health-equity)
- [Partnerships ](https://blog.acclinate.com/tag/partnerships)
- [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare)

[Health Equity](https://blog.acclinate.com/topic/health-equity)

# Cox Enterprises Social Impact Accelerator Class 2021 - Acclinate

 Ten companies were selected to address systematic racism and social justice

![Cox Enterprises Social Impact Accelerator Class 2021 - Acclinate](https://blog.acclinate.com/hubfs/64ee7ebf711c42cfdd7be9a7_bZtPp92g.jpeg)

 Clinical Trial Diversity: What Does It Really Mean?

 Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t...

Read More 

<https://blog.acclinate.com/cox-enterprises-social-impact-accelerator-announces-2021-class#>

![ Acclinate](https://blog.acclinate.com/hubfs/69b96486c4b036c19f462c19_acclinate-logo.png)

[Acclinate](https://blog.acclinate.com/author/acclinate)

 Acclinate turns trust and data into better representation.

 Share this Post:

[**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/cox-enterprises-social-impact-accelerator-announces-2021-class) [**](https://twitter.com/home?status=https://blog.acclinate.com/cox-enterprises-social-impact-accelerator-announces-2021-class) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/cox-enterprises-social-impact-accelerator-announces-2021-class&title=Cox%20Enterprises%20Social%20Impact%20Accelerator%20Class%202021%20-%20Acclinate)

Stay up to date

 Get news directly in your inbox

ATLANTA, Jan. 25, 2021 /PRNewswire/ -- Cox Enterprises has announced the 2021 class of the Cox Enterprises [Social Impact Accelerator](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=152725518&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D2718637690%26u%3Dhttps%253A%252F%252Fwww.coxenterprises.com%252Fabout-us%252Finnovation%252Ftechstars-impact%26a%3DSocial%2BImpact%2BAccelerator&a=Social+Impact+Accelerator) powered by Techstars. Now in its second year, the program has shifted focus to support companies addressing social justice and systemic racism issues. The three-month program will provide virtual mentoring, funding and global connections to 10 for-profit, mission-driven companies.

Strategic mentorships with Cox business leaders and experts will help bring the entrepreneurs' ideas to market, boost their early-stage businesses, grow their networks and prepare them to pitch their company's ideas to potential investors at a Demo Day presentation on April 29, 2021.

"This class gives me confidence that we can and will make this country a more equitable and inclusive place to live," said Barry Givens, managing director of Techstars Social Impact. "We hope this class will be a shining example of the opportunities that exist to impact social justice and will highlight the importance of supporting diverse founders who are tackling these issues."

The 2021 Social Impact Accelerator class includes:

- [Acclinate](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=3611929009&u=http%3A%2F%2Fwww.acclinate.com%2F&a=Acclinate): Educates and engages diverse individuals to make informed decisions about genomic research and clinical trial participation.
- [Co:census](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2279416248&u=https%3A%2F%2Fcocensus.io%2F&a=Co%3Acensus): Enhances equity in social surveys intended to assess community needs for people of color and/or with limited English proficiency.
- [COMMUNITYx](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=4213658545&u=https%3A%2F%2Fwww.communityx.tech%2F&a=COMMUNITYx): Enables users to create and scale cause-driven communities that are ready to mobilize, from anywhere in the world.
- [Empowrd](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=860509229&u=https%3A%2F%2Fwww.empowrd.com%2F&a=Empowrd): Personalizes and guides civic engagement experiences that inspire, inform and enable civic participation.
- [Govrn](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2991238325&u=https%3A%2F%2Fwww.govrn.io%2F&a=Govrn): Makes politics simple, transparent and effective for people who want democracy to be more trustworthy.
- [JusticeText](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=791184083&u=https%3A%2F%2Fjusticetext.com%2F&a=JusticeText): Strengthens the ability of public defenders to analyze critical video and audio data by enabling users to upload body camera footage, interrogation videos, courtroom proceedings and jail calls.
- [Legal Equalizer](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=114783591&u=https%3A%2F%2Flegalequalizer.com%2F&a=Legal+Equalizer): Connects people with five eyewitnesses, shares legal information and alerts loved ones in real-time during law enforcement encounters.
- [Minwo](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=533801635&u=https%3A%2F%2Fwww.minwo.co%2F&a=Minwo): Connects venture capital firms and incubators with minority and women-owned businesses to accelerate their growth and close the wealth gap.
- [STRE.ME](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=3257502005&u=https%3A%2F%2Fstre.me%2F&a=STRE.ME): Creates unique educational experiences for individuals to learn how to manage their biases in a safe, convenient and confidential manner.
- [Unpacking](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2127046689&u=https%3A%2F%2Funpacking.co%2F&a=Unpacking): Builds culturally competent teams through an online learning platform that navigates historical context, real world scenarios and interactive gaming.

"We believe this is the right time for Cox to be a force for good and further our commitment to equity," said Maury Wolfe, assistant vice president of corporate responsibility and public affairs at Cox Enterprises. "Finding new, innovative solutions to solve one of this country's biggest issues is at the forefront for this class. At Cox, we are passionate about creating lasting change for generations to come, and we hope these ideas will help get us there."

The Social Impact Accelerator is the second accelerator in partnership between Techstars and Cox Enterprises. Cox also funds and supports startups and entrepreneurs through other Atlanta-based partnerships, including [Techstars Atlanta](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2551701099&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D2352333%26u%3Dhttps%253A%252F%252Fwww.coxenterprises.com%252Fabout-us%252Finnovation%252Ftechstars-atlanta%26a%3DTechstars%2BAtlanta&a=Techstars+Atlanta), [Engage](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2430850401&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D1875554074%26u%3Dhttps%253A%252F%252Fwww.coxenterprises.com%252Fabout-us%252Finnovation%252Fengage%26a%3DEngage&a=Engage), [Endeavor](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=1290361453&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D1434551511%26u%3Dhttps%253A%252F%252Fwww.endeavoratlanta.org%252F%26a%3DEndeavor&a=Endeavor) and [Startup Runway](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=446559227&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D1362277464%26u%3Dhttps%253A%252F%252Fstartuprunway.co%252F%26a%3DStartup%2BRunway&a=Startup+Runway).  

For more information about Cox Enterprises' involvement in the venture ecosystem, visit[ www.coxenterprises.com/innovation](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=2435654624&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2932076-1%26h%3D3770845117%26u%3Dhttp%253A%252F%252Fwww.coxenterprises.com%252Finnovation%26a%3D%25C2%25A0www.coxenterprises.com%252Finnovation&a=%C2%A0www.coxenterprises.com%2Finnovation).

‍[Original Article](https://www.prnewswire.com/news-releases/cox-enterprises-social-impact-accelerator-powered-by-techstars-announces-2021-class-301214070.html)

__

### **About Cox Enterprises**

Cox Enterprises is dedicated to building a better future through our leading communications, automotive and media companies. Our major operating subsidiaries include Cox Communications and Cox Automotive, and we are strategically investing in new industries and emerging technologies, with sizeable interests in clean technology and health care. Headquartered in Atlanta, Georgia, Cox is a global company with nearly $20 billion in annual revenues and brands that include Autotrader, Kelley Blue Book and Cox Homelife. Founded in 1898 by Ohio Governor James M. Cox, the company is a family-owned business committed to its people, communities and planet. To learn more about Cox, visit coxenterprises.com, view our Sustainability Report at coxcsrreport.com, or follow us on Twitter via @CoxEnterprises or @AlexTaylor_Cox.‍

### **About Techstars**

Techstars is the worldwide network that helps entrepreneurs succeed. Techstars founders connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporations to grow their companies. Techstars operates three divisions: Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, and Techstars Corporate Innovation Partnerships. Techstars accelerator portfolio includes more than 1,900 companies with a market cap of more than $25 billion.

[www.techstars.com](https://c212.net/c/link/?t=0&l=en&o=3045793-1&h=4047934466&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2703041-1%26h%3D1754221334%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2492232-1%2526h%253D3166750284%2526u%253Dhttp%25253A%25252F%25252Fwww.techstars.com%25252F%2526a%253Dwww.techstars.com%26a%3Dwww.techstars.com&a=www.techstars.com)

SOURCE Cox Enterprises

### Related Links

[www.coxenterprises.com](http://www.coxenterprises.com/)

## Recent Posts

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) 

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

<https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

 June 25, 2026

 3 Min Read

 Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr...

Read More

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) 

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

<https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

 June 25, 2026

 3 Min Read

 For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle...

Read More

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) 

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

<https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

[ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

 June 25, 2026

 3 Min Read

 Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s...

Read More

[![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) 

](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>[ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

 June 24, 2026

 1 Min Read

 Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h...

Read More

[![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) 

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

<https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

[ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

 March 2, 2026

 3 Min Read

 For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality.

Read More

[![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) 

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

<https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

[ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

 February 16, 2026

 3 Min Read

 Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h...

Read More

[![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) 

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

<https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

[ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

 February 9, 2026

 3 Min Read

 Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical...

Read More

[![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) 

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

<https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

[ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

 February 2, 2026

 2 Min Read

 Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ...

Read More

[![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) 

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

<https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

[ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

 January 26, 2026

 3 Min Read

 Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited...

Read More

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp)

 June 25, 2026 

 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World

Read More

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp)

 June 25, 2026 

 Clinical Trial Generalizability: What Regulators Will Scrutinize Next

Read More

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp)

 June 25, 2026 

 Site Engagement Index (SEI): Measuring What Actually Builds Trust

Read More

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp)

![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp)

![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp)

## Ready to Measure Your True Impact?

 Partner with Acclinate to turn mission into measurable, data-driven action.

[ Get Started ](https://www.acclinate.com/contact-us)

[![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/)

- Products
- [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
- [e-DICT](https://www.acclinate.com/products/e-dict)

- Solutions
- [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
- [CROs](https://www.acclinate.com/solutions/for-cros)
- [Community Partners](https://www.acclinate.com/solutions/community-partners)

- Resources
- [Resources Hub](https://www.acclinate.com/resources)
- [Glossary](https://www.acclinate.com/glossary)
- [Press Kit](https://www.acclinate.com/press-kit)
- [Events](https://www.acclinate.com/events)
- [News](https://news.acclinate.com/)
- [Blog](https://blog.acclinate.com/)
- [FAQs](https://www.acclinate.com/faq)

- Company
- [About us](https://www.acclinate.com/about)
- [Careers](https://www.acclinate.com/careers)
- [Contact Us](https://www.acclinate.com/contact-us)

- Follow Us
- [** Linkedin](https://www.linkedin.com/company/acclinateinc/)

- [Privacy Policy](https://www.acclinate.com/privacy)
- [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Acclinate",
    "url" : "https://blog.acclinate.com/author/acclinate"
  },
  "dateModified" : "2024-03-21T17:09:27.639Z",
  "datePublished" : "2021-01-25T13:30:00.000Z",
  "headline" : "Cox Enterprises Social Impact Accelerator Class 2021 - Acclinate",
  "image" : [ "https://blog.acclinate.com/hubfs/64ee7ebf711c42cfdd7be9a7_bZtPp92g.jpeg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.acclinate.com/cox-enterprises-social-impact-accelerator-announces-2021-class",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png"
    },
    "name" : "Acclinate"
  }
}
```